Objective To examine the contribution of six cardiovascular polymorphisms to the occurrence of a first event of ischemic heart disease (IHD) in a primary care population with a high prevalence of hypertension. Furthermore, we specified the data for sex and age.
Introduction
The rennin-angiotensin system (RAS) plays an important role in vascular homeostasis. The biochemical cascade concerns the sequential cleavage of angiotensinogen (AGT) by renin to angiotensin I, and subsequently by angiotensin converting enzyme (ACE) to angiotensin II (Ang II). Besides regulating blood pressure, the vasoactive peptide Ang II has a number of other actions, eventually leading to the formation of atherosclerotic lesions [1] [2] [3] . Therefore, it is commonly accepted that components of the RAS play a role in atherosclerosis and thromboembolic events, for example, ischemic heart disease (IHD) and stroke [4] [5] [6] . Many studies have attempted to relate genetic variants of components of RAS to cardiovascular disease [7] . Among the many potential genes, those related to activation of the RAS or to an increased tendency to retain sodium rank high and so do genes, which may cause reduced availability of nitric oxide (NO). To date, however, findings from association studies involving the RAS genes remain inconsistent and controversial [6, 8] . An important reason for this inconsistency is that most of these observations have been obtained in selected populations and the variability of cardiovascular endpoints [8] .
This prompted us to perform a genetic association study on IHD in a primary care population. Based on the literature available at the start of the study, we restricted ourselves to the analysis of six polymorphisms. These were the AGT (M235 T), ACE (4656 rpt ), and the angiotensin II type 1 receptor [AGTR1 (A1166C)] polymorphism that are involved in the generation and action of Ang II. In addition, a-adducin [ADD1 (G460W)], G-protein b3 subunit [GNB3 (C825 T)], and the endothelial nitric oxide synthase [NOS3 (E298D)] polymorphisms, as markers of sodium retaining tendency and altered NO availability, were selected, respectively. The selection criterion for IHD was narrowed down to a first event of IHD. To further reduce the variability of the association with the first event of IHD, we specified the data for sex and age [8] [9] [10] . We hypothesized that the presence of one or more mutant alleles of aforementioned six polymorphisms would affect the occurrence of a first event, and that these associations are modified by sex and age. To do so, in this study, we assessed the contribution of these parameters to patients with a first event of IHD in comparison with control participants without IHD.
Methods

Participants
For this study we used data from the HIPPOCRATES (Hypertension: Interaction and Prevalence of Polymorphisms related to Cardiovascular Risk and the Association to Treatment Efficacy Study) project. The HIPPOCRATES is an ongoing study, in which the implementation of genetic polymorphisms in the assessment of cardiovascular risk in primary care is investigated [11] [12] [13] . This study uses the population of one large general practice in Kerkrade, which is located in the southeast of the Netherlands, and is characterized with a high burden of cardiovascular disease compared with the average of the Netherlands [13] . This academic general practice takes part in the Registration Network Family Practices, which is a continuous and computerized database in which 63 general practitioners, working in 22 different practices, in the south of the Netherlands participate. All relevant health problems, including a full medical history of all cardiovascular events, have been registered since 1990 [14, 15] . Medical problems are coded according to the International Classification of Primary Care using the criteria of the International Classification of Health Problems in Primary Care for diagnoses [16, 17] . The general practice in Kerkrade has a list of approximately 4400 patients among whom more than 2300 patients are of age 40 years and above. The practice has well implemented cardiovascular consulting hours. For the HIPPOCRATES, all known patients aged at least 40 years with cardiovascular disease or hypertension were invited. From the group with other cardiovascular risk factors, which is smoking, alcohol, diabetes mellitus, hypercholesterolemia, overweight including obesity, a random 1 : 3 sample was taken. Of all patients without known cardiovascular disease, hypertension or other cardiovascular risk factors, a random 1 : 3 sample was taken. The initial classification was validated by a thorough assessment of the patients' records combined with additional measurements of risk factors for all participants. The total HIPPOCRATES population consisted of 803 patients (382 males, 421 females), who were recruited between May 2003 and July 2005.
The study population for this cross sectional case-control study consisted of 728 Caucasian participants: 157 patients with a known first event of IHD (cases) and 571 event-free participants without documented cardiovascular disease (controls). IHD was defined as having a diagnosis of angina pectoris, myocardial infarction, or heart failure. A first event was defined as the first diagnosis of IHD, which was present in the medical registration. An event-free control participant had no IHD, stroke, peripheral artery occlusive disease, or heart failure.
Clinical data collection
Data on risk factors were collected from the Registration Network Family Practices from the period before the first event till 1 year after the event. The latter was done as data on risk factors are not immediately available owing to the delay of data entry of medical problems in the registration. Overweight was defined as having a body mass index of at least 27 (International Classification of Primary Care: T82, T83). Data on smoking behaviour and alcohol consumption were collected. Hypertension was defined as a systolic blood pressure of 140 mmHg or less and/or diastolic blood pressure of 90 mmHg or less (diagnosis K86 or K87, respectively) according to the Guidelines for hypertension specified by the European Society of Hypertension [18] or use of antihypertensive drugs. Hypercholesterolemia was defined as having a diagnosis of T93 (dyslipidemia) or use of lipid-lowering drugs. Diabetes mellitus was considered to be present in case of fasting plasma glucose levels greater than 6.9 mmol/l (diagnosis T90) or the use of oral antidiabetic drugs or insulin. The computerized medication lists were analysed for antihypertensive, antidiabetic, antiplatelet, and hypolipidemic medication. All relevant data on medication were collected in the period before the first event. All patients gave written informed consent to participate in the study. The study was approved by the Medical Ethics Committee of the University Hospital Maastricht.
Genetic analyses
The various polymorphisms were determined at the Cardiovascular Genotyping laboratory of the Department of Internal Medicine of the University Hospital Maastricht. DNA was extracted from whole blood with the use of the QIAmp Blood Kit (Qiagen Inc., Valencia, USA). Genotyping of the AGTR1 (A1166C), AGT (M235 T), ACE (4656 rpt ), NOS3 (E298D), GNB3 (C825 T), and ADD1 (G460W) polymorphisms was performed with a multiplex single base extension (SBE) assay (Multiplex SNaPshot, Applied Biosystems, Foster City, California, USA) similar to previously published protocols [19] . Briefly, in the first stage a multiplex PCR is carried out to amplify the gene fragments that contain the polymorphisms. In the second stage, the polymorphic positions are interrogated by a SBE reaction using fluorescently labeled ddNTPs. The oligos used for the SBE have specific lengths, varying from 22 to 50 nucleotides. After the SBE assay, the fragments are size-resolved on an ABI3100 Genetic Analyser (Applied Biosystems, Carlsbed, California, USA): the size of the peaks identifies the locus (e.g. ADD1) and the color of the peak(s) identifies the genotype (e.g. Gly/Trp). Raw data were analyzed with Genescan Analysis software (version 3.7, PE Applied Biosystems, PerkinElmer Inc., Waltham, Massachusetts, USA), then genotypes were scored independently by two researchers and entered in the database. In 27 patients, a second analysis was necessary to obtain all the genotypes. The ACE insertion/deletion (I/D) polymorphism was determined by detecting ACE 4656 + CT observed on the SNaPshot as ACE (4656 rpt ). The use of this SNaPshot method does not allow the direct determination of the I/D polymorphism. The ACE 4656 + CT polymorphism in the 3 0 -untranslated region of the ACE gene consists of a repetition of two or three CT dinucleotides and is in complete linkage disequilibrium with ACE (I/D) polymorphism [20, 21] . The multiplex assay was validated on a set of 100 DNA samples that had previously been genotyped with an alternative technique; this technique concerned a multilocus genotyping assay for candidate markers of cardiovascular disease risk (Roche Molecular systems Inc., Pleasanton, California, USA) and has been described in detail previously [22] . Only four samples gave a discordant result for the endothelial constitutive NOS (ecNOS) polymorphism. All other genotypes were concordant. The discordant results have been adjusted.
Statistical analyses
Statistical analysis was performed using SPSS statistical software, version 13.0 (SPSS, Inc., Chicago, Illinois, USA). A P value of 0.05 or less was considered statistically significant. Bonferonni correction was applied for multiple testing. Statistical significance for differences in quantitative variables between males and females with IHD and event-free male and female controls was tested in case of continuous variables by one-way analysis of variance and the w 2 test was used in case of categorical variables. Genotype and allele frequencies were calculated to test the Hardy-Weinberg equilibrium. Allele frequencies were analyzed using w 2 tests. Only differences in allele frequencies larger than 0.04 between and within males and females were tested for significance.
Logistic regression analyses
Both univariate and multivariate odds ratios (ORs) were calculated with a binary-logistic regression model (method: enter) to evaluate the relationship between polymorphisms and a first event of IHD. For that purpose, dummy variables were created using the homozygous wild-type genotype as reference category. For females only univariate ORs could be calculated, owing to the low number of patients who were available to perform meaningful multivariate regression analyses. Age and sex were incorporated in both the univariate as well as in the multivariate logistic regression analyses. As indicated, control participants were selected from different groups. Therefore, in the logistic regression analyses we had to adjust for this selection and dummy variables had to be created using the normotensive group without cardiovascular risk factors as the reference category. Adjustment for potential confounders was performed by incorporating smoking, alcohol, overweight, diabetes mellitus, and hypercholesterolemia into these models. The simultaneous contribution of the six polymorphisms to the prediction of a first event of IHD was tested, using a likelihood ratio test. If two or more polymorphisms reached statistical significance, interactions (effect modification) between two polymorphisms with respect to a first event of IHD were assessed. Again binary-logistic regression analysis (method: enter) was used, in which the alleles at risk, the interaction term between the alleles and the other covariates were incorporated. If an interaction term became statistically significant, the model was explored further.
Sliding means analyses
To explore the influence of increasing age on the risk of a first event of IHD within males or females the sliding means technique for ORs was applied [23] . According to this approach, subgroups of 328 participants were formed based on increasing age. Each subgroup differed from the preceding or succeeding subgroup by 10 individuals. For each subgroup a binary-logistic regression analysis (method: enter) was carried out to explore the relation between carriership of the mutant allele and a first event of IHD. Covariates were not incorporated because the number of patients available per data point did not allow meaningful regression analyses. For both males and females a curve was fitted using STATA Graph 8.2 (Stata Inc., College Station, Texas, USA; Lowess smoothing technique) [23] . Differences between males and females were tested by comparing the area under the curve, which represents the mean OR calculated for the relevant polymorphism in the univariate analyses.
Results
General characteristics
Baseline characteristics of the study population are summarized in Table 1 . Overall, the first event group differed from the control group with respect to established cardiovascular risk factors, except for the occurrence of hypertension and diabetes. For both male and female cases, the mean age at which the first cardiovascular event occurred was below 60 years. On average, male cases smoked more cigarettes and used more alcohol. Cases with a first IHD event used more often antihypertensive, antidiabetic, antiplatelet, and hypolipidemic medication as compared with controls. There was no statistically significant difference between male and female cases in terms of the presence of overweight, hypertension, diabetes, and hypercholesterolemia. The control group contained more females than males; their mean age was comparable with the first event group.
Genetic analyses
Genotype and allele frequencies of all polymorphisms were in Hardy-Weinberg equilibrium. No statistically significant differences in allele frequencies were found between cases and controls, except between male cases with IHD and male controls for GNB3 (P = 0.03) and between male and female controls for ecNOS (P = 0.04) ( Table 2 ). In addition, for AGT a borderline statistically significant difference in allele frequency was observed (P = 0.08) between males with IHD and male controls. Other differences in allele frequency, that is, larger than 0.04 between and within males and females were not statistically significant.
Logistic regression analyses
Both univariate and multivariate ORs for a first IHD event were calculated (Table 3 ). In the multivariate analysis, the simultaneous contribution of the six polymorphisms to the prediction of a first event was statistically significant for all participants and males, respectively (likelihood ratio test; P < 0.001), showing a protective association for carriership of the T-allele of the AGT polymorphism [OR = 0.58 (0.27-0.89)]. After Bonferonni correction, this association was still statistically significant (P = 0.04). In addition, we found a trend towards a protective effect for AGTR1 [OR = 0.65 (0.42-1.01)], which was also observed for females in the univariate analysis [OR = 0.56 (0.29-1.09)]. In all other polymorphisms, carriership of the mutant allele of the investigated polymorphisms was not associated with an increased risk of IHD. Evaluation of possible interactions between AGT and AGTR1 showed no statistically significant interaction terms for both males and females together or for males alone.
Sliding means analyses
For AGT the effect of increasing age was explored by the sliding means technique for ORs (Fig. 1) . For males a protective trend was observed, whereas in females the T-allele is harmful till the age of approximately 65 years. This observed difference between males and females was statistically significant (P < 0.001). The maximum OR for the Lowess-curve in female cases was estimated 1.6 at the age of 56 years.
Discussion
In this study, no statistically significant differences in allele frequencies were found between cases and controls, except for a higher frequency of the T-allele of GNB3 (P = 0.03) in male cases compared with male controls and a higher frequency of the T-allele of ecNOS (P = 0.04) in female controls compared with male controls. However, multivariate analyses showed a protective association for carriership of the T-allele of AGT, overall [OR = 0.69 (0.34-0.90)] and for males [OR = 0.58 (0.27-0.89)]. Sliding mean analyses indicated a statistically significant, but opposite age-associated trend for this polymorphism between males and females.
Sex and age
Sex-specific associations of cardiovascular phenotypes with a variety of candidate genes have been previously reported [24] [25] [26] [27] [28] . In most cases, they appear as rather unexpected findings and are difficult to explain in terms of straightforward pathophysiological mechanisms. These kinds of results are often marked as type I errors owing to sample stratification with consequent multiple comparisons and in some cases a small number of individuals in a subgroup [29] . Our study is certainly not protected from such a risk. However, a few considerations may support the plausibility of a sex-specific association. First of all, sex was a statistically significant covariate in the overall multivariate analyses, irrespective of correction for multiple testing. Second, it is known from literature, that hypertension and IHD are age dependent [30, 31] , and that females develop both conditions at an older age [30] [31] [32] [33] . However, in our study population the age at onset for IHD is approximately the same for both males and females (Table 1) . As age-related phenotypes (e.g. overweight, hypertension, diabetes, and hypercholesterolemia) are present to the same extent for both male and female cases, a sex-specific association is plausible in our study. The influence of age on the association of cardiovascular polymorphisms with cardiovascular phenotypes has not yet been completely elucidated. Several authors have underlined the importance of taking into account pathophysiological changes related to ageing when analysing the phenotypic effect of genetic variants [34, 35] . For instance, Province et al. [34] found in a study in which they investigated the association of higher blood pressure values with ADD1 (G460W) that this association was observed only in older individuals. They discussed that this is probably due to a reduced efficiency of compensatory mechanisms at an older age.
Angiotensinogen (M235 T) polymorphism
The opposing associations of the T-allele of AGT with IHD for males and females need further explanation. Recently, a meta-analysis by Sethi et al. [36] , including 127 studies (n = 45 267) stratified by sex, concluded that the M235 T polymorphism did not predict risk of IHD or The wild type alleles were used as reference category. **P r 0.05, multivariate adjustment was performed for age, sex, smoking, alcohol, overweight, diabetes mellitus and hypercholesterolemia. 
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Sliding odds ratio analysis of the interaction between carriership of the T allele of angiotensinogen and age for males and females with respect to the risk of a first event of ischemic heart disease. Each endpoint represents the unadjusted odds ratio (T-allele versus MM genotype) of 328 individuals according to age and sex and differs from the preceding or succeeding point by 10 individuals. The observed difference between males and females is statistically significant (P < 0.001).
myocardial infarction, neither for males nor females. However, when looking in detail in their data these authors also showed a harmful association for women homozygous for the T-allele and a protective association for males. These data were however not statistically significant. Another recent study performed by Sekuri et al. [37] found that patients with the TT-genotype had a decreased risk of premature coronary heart disease. Such an association was reported earlier for myocardial infarction [38] . However, in both studies no subgroup analysis was performed on sex.
A speculative explanation for our observations might be a low renin state, which can be enhanced by the GNB3 (C825 T) polymorphism and older age [39] [40] [41] . A protective association for the T-allele of AGT may, under these conditions, be related to lower angiotensin levels. This was confirmed by a study performed by FernandezArcas et al. [38] who indeed found a suppressed RAS in carriers of the T-allele of AGT. In combination with the higher frequency of the T-allele of GNB3 in males, this could translate to the observed ORs. This is also suggested by Schunkert et al. [39] who hypothesized that the difference between males and females is rather a genetic alternation than an effect induced by blood pressure. Another explanation might be the recently indicated misclassification of the AGT (M235 T) genotype [42] . However, in our study the validation process of our multiplex assay did not reveal discordant results for this polymorphism.
Strengths and limitations
This study has several limitations. First, we only studied the effect of one polymorphism per gene, which does not exclude the role of other polymorphic alleles, which are not in linkage disequilibrium. Another limitation for this study as is for many genetic association studies is sample size. It has been emphasized that sample sizes of thousands are required to have adequate power to detect genes conferring ORs as low as 1.2, with minor allele frequencies in the range of 5-10% [43] . In our study the actual allele frequencies of the mutant alleles ranged between 0.22 and 0.55, and the ORs for a first event were much larger than 1.2, indicating that the sample size of our study, at least for the AGT polymorphism, was acceptable. Furthermore, one could object that the definition of IHD included heart failure. However, in primary care the diagnosis of heart failure is mostly caused by an event of angina pectoris or myocardial infarction. Indeed, after exclusion of heart failure events the observed association remained unchanged.
Our study has also some unique aspects, including a primary care population in which the whole range of low to high-risk patients is available. Although our study has an exploratory character, we performed this study with a clear priori hypothesis, therefore reducing multiple hypothesis testing. In addition, our population was selected using strict inclusion criteria and was derived from a rather small area, including participants with similar social living conditions.
In conclusion, this study provides evidence that in this primary care population the T-allele of the AGT polymorphism is protective for males with a first event of IHD. Our data confirm that age and sex are not simply confounders in genetic epidemiology but represent a key to a better understanding of the underlying mechanisms of pathological phenotypes.
